Nature and nurture in Foxp3 + regulatory T cell development, stability, and function

Human Immunology

Volumn 73, Issue 3, 2012, Pages 232-239

  Geiger, Terrence L ^a   Tauro, Sharyn ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cellular differentiation; Foxp3; Immune regulation; Regulatory T lymphocyte

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE; THYMUS GLAND;

EID: 84857121188     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.012     Document Type: Review

References (133)

1. Jäger A., Kuchroo V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 2010, 72:173-184.
2. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331-337.
3. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500.
4. Zhou X., Bailey-Bucktrout S., Jeker L.T., Bluestone J.A. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 2009, 21:281-285.
5. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009, 106:1903-1908.
6. Curotto de Lafaille M.A., Lafaille J.J. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
7. Horwitz D.A., Zheng S.G., Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 2008, 29:429-435.
8. Wang L., Bosselut R. CD4-CD8 lineage differentiation: Thpok-ing into the nucleus. J Immunol 2009, 183:2903-2910.
9. Collins A., Littman D.R., Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat Rev Immunol 2009, 9:106-115.
10. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
11. + regulatory T cells. Nat Immunol 2003, 4:330-336.
12. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
13. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
14. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
15. Hori S. Rethinking the molecular definition of regulatory T cells. Eur J Immunol 2008, 38:928-930.
16. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007, 5:e38.
17. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
18. Lal G., Zhang N., van der Touw W., Ding Y., Ju W., Bottinger E.P., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009, 182:259-273.
19. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H.C., Greene M.I., et al. Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
20. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
21. + subset. J Immunol 2009, 183:2261-2266.
22. Pennington D.J., Silva-Santos B., Silberzahn T., Escórcio-Correia M., Woodward M.J., Roberts S.J., et al. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 2006, 444:1073-1077.
23. Lio C.W., Dodson L.F., Deppong C.M., Hsieh C.S., Green J.M. CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J Immunol 2010, 184:6007-6013.
24. Bensinger S.J., Bandeira A., Jordan M.S., Caton A.J., Laufer T.M. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 2001, 194:427-438.
25. Ribot J., Enault G., Pilipenko S., Huchenq A., Calise M., Hudrisier D., et al. Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection. J Immunol 2007, 179:6741-6748.
26. Liston A., Nutsch K.M., Farr A.G., Lund J.M., Rasmussen J.P., Koni P.A., et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci U S A 2008, 105:11903-11908.
27. + regulatory T cells in vivo. J Exp Med 2003, 198:249-258.
28. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci U S A 2002, 99:8213-8218.
29. + regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen. J Immunol 2008, 180:2149-2157.
30. Alli R., Nguyen P., Geiger T.L. Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J Immunol 2008, 181:136-145.
31. + T cell receptors. Immunity 2004, 21:267-277.
32. Liu X., Nguyen P., Liu W., Cheng C., Steeves M., Obenauer J.C., et al. T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells. Immunity 2009, 31:909-920.
33. Pacholczyk R., Ignatowicz H., Kraj P., Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 2006, 25:249-259.
34. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 2006, 7:401-410.
35. Romagnoli P., Hudrisier D., van Meerwijk J.P. Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J Immunol 2002, 168:1644-1648.
36. + T-cell development in a mouse expressing a transgenic TCR derived from a Treg. Eur J Immunol 2009, 39:234-240.
37. Simons D.M., Picca C.C., Oh S., Perng O.A., Aitken M., Erikson J., et al. How specificity for self-peptides shapes the development and function of regulatory T cells. J Leukoc Biol 2010, 88:1099-1107.
38. Ohkura N., Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin Immunopathol 2010, 32:95-106.
39. Pacholczyk R., Kern J. The T-cell receptor repertoire of regulatory T cells. Immunology 2008, 125:450-458.
40. Romagnoli P., van Meerwijk J.P. Thymic selection and lineage commitment of CD4(+)Foxp3(+) regulatory T lymphocytes. Prog Mol Biol Transl Sci 2010, 92:251-277.
41. Wheeler K.M., Samy E.T., Tung K.S. Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity. J Immunol 2009, 183:7635-7638.
42. Lathrop S.K., Santacruz N.A., Pham D., Luo J., Hsieh C.S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med 2008, 205:3105-3117.
43. Nguyen P., Liu W., Ma J., Manirarora J.N., Liu X., Cheng C., et al. Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis. J Immunol 2010, 185:3895-3904.
44. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007, 13:423-431.
45. Pacholczyk R., Kern J., Singh N., Iwashima M., Kraj P., Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 2007, 27:493-504.
46. Leung M.W., Shen S., Lafaille J.J. TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes. J Exp Med 2009, 206:2121-2130.
47. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol 2009, 10:610-617.
48. Hanabuchi S., Ito T., Park W.R., Watanabe N., Shaw J.L., Roman E., et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 2010, 184:2999-3007.
49. - precursors. J Immunol 2002, 169:4183-4189.
50. Selvaraj R.K., Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 2007, 178:7667-7677.
51. Davidson T.S., Dipaolo R.J., Andersson J., Shevach E.M. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 2007, 178:4022-4026.
52. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008, 9:194-202.
53. Kim H.P., Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007, 204:1543-1551.
54. Maruyama T., Li J., Vaque J.P., Konkel J.E., Wang W., Zhang B., et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol 2011, 12:86-95.
55. + DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007, 204:1757-1764.
56. Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008, 111:1013-1020.
57. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
58. Liu G., Yang K., Burns S., Shrestha S., Chi H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol 2010, 11:1047-1056.
59. +Foxp3+ cells. J Exp Med 2008, 205:565-574.
60. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009, 206:3015-3029.
61. Kopf H., de la Rosa G.M., Howard O.M., Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol 2007, 7:1819-1824.
62. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 2008, 105:7797-7802.
63. Ouyang W., Beckett O., Ma Q., Paik J.H., DePinho R.A., Li M.O. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 2010, 11:618-627.
64. Harada Y., Harada Y., Elly C., Ying G., Paik J.H., DePinho R.A., et al. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 2010, 207:1381-1391.
65. Kerdiles Y.M., Stone E.L., Beisner D.R., McGargill M.A., et al. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
66. Gottschalk R.A., Corse E., Allison J.P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 2010, 207:1701-1711.
67. Oliveira V.G., Caridade M., Paiva R.S., Demengeot J., Graca L. Sub-optimal CD4 T cell activation triggers autonomous TGF-beta-dependent conversion to Foxp3(+) regulatory T cells. Eur J Immunol 2011, 41:1249-1255.
68. Tai X., Cowan M., Feigenbaum L., Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005, 6:152-162.
69. Golovina T.N., Mikheeva T., Suhoski M.M., Aqui N.A., Tai V.C., Shan X., et al. CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 2008, 181:2855-2868.
70. Semple K., Nguyen A., Yu Y., Wang H., Anasetti C., Yu X.Z. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 2011, 117:3096-3103.
71. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005, 201:127-137.
72. Apostolou I., von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004, 199:1401-1408.
73. Tsuji M., Komatsu N., Kawamoto S., Suzuki K., Kanagawa O., Honjo T., et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
74. Mucida D., Kutchukhidze N., Erazo A., Russo M., Lafaille J.J., Curotto de Lafaille M.A. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005, 115:1923-1933.
75. Verginis P., McLaughlin K.A., Wucherpfennig K.W., von Boehmer H., Apostolou I. Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc Natl Acad Sci U S A 2008, 105:3479-3484.
76. Daniel C., Ploegh H., von Boehmer H. Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol Biol 2011, 707:173-185. 173-185.
77. Getnet D., Grosso J.F., Goldberg M.V., Harris T.J., Yen H.R., Bruno T.C., et al. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol 2010, 47:1595-1600.
78. Thornton A.M., Korty P.E., Tran D.Q., Wohlfert E.A., Murray P.E., Belkaid Y., et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010, 184:3433-3441.
79. Verhagen J., Wraith D.C. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.". J Immunol 2010, 185:7129.
80. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
81. + T regulatory cells. Nat Immunol 2003, 4:337-342.
82. + T cells. J Immunol 2004, 172:2238-2246.
83. Inaba H., Geiger T.L. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes. Int Immunol 2006, 18:1043-1054.
84. Inaba H., Steeves M., Nguyen P., Geiger T.L. In vivo suppression of naive CD4 T cell responses by IL-2- and antigen-stimulated T lymphocytes in the absence of APC competition. J Immunol 2008, 181:3323-3335.
85. Jooss K., Gjata B., Danos O., von Boehmer H., Sarukhan A. Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A 2001, 98:8738-8743.
86. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
87. Feuerer M., Hill J.A., Kretschmer K., von Boehmer H., Mathis D., Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A 2010, 107:5919-5924.
88. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625.
89. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010, 11:1093-1101.
90. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197.
91. Lal G., Yin N., Xu J., Lin M., Schroppel S., Ding Y., et al. Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of foxp3 expression and Treg function. Am J Transplant 2011, 11:203-214.
92. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 2007, 178:280-290.
93. Bayer A.L., Yu A., Malek T.R. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 2007, 178:4062-4071.
94. Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
95. + regulatory T cells. J Exp Med 2005, 201:1061-1067.
96. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
97. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008, 205:1983-1991.
98. Duarte J.H., Zelenay S., Bergman M.L., Martins A.C., Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009, 39:948-955.
99. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martínez-Llordella M., Ashby M., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009, 10:1000-1007.
100. Rubtsov Y.P., Niec R.E., Josefowicz S., Li L., Darce J., Mathis D., et al. Stability of the regulatory T cell lineage in vivo. Science 2010, 329:1667-1671.
101. + T lymphocytes. Proc Natl Acad Sci U S A 2005, 102:11817-11822.
102. Zheng S.G., Meng L., Wang J.H., Watanabe M., Barr M.L., Cramer D.V., et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int Immunol 2006, 18:279-289.
103. Weber S.E., Harbertson J., Godebu E., Mros G.A., Padrick R.C., Carson B.D., et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 2006, 176:4730-4739.
104. + T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008, 223:391-421.
105. Selvaraj R.K., Geiger T.L. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J Immunol 2008, 180:2830-2838.
106. Wong J., Mathis D., Benoist C. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J Exp Med 2007, 204:2039-2045.
107. Hindley J.P., Ferreira C., Jones E., Lauder S.N., Ladell K., Wynn K.K., et al. Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res 2011, 71:736-746.
108. + T cells. PLoS ONE 2010, 5:e13623.
109. Fourcade J., Sun Z., Kudela P., Janjic B., Kirkwood J.M., El-Hafnawy T., et al. Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire. J Immunol 2010, 184:6709-6718.
110. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007, 204:1775-1785.
111. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
112. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
113. Lyons A., O'Mahony D., O'Brien F., MacSharry J., Sheil B., Ceddia M., et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 2010, 40:811-819.
114. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
115. Lord G.M., Rao R.M., Choe H., Sullivan B.M., Lichtman A.H., Luscinskas F.W., et al. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005, 106:3432-3439.
116. Clark-Lewis I., Mattioli I., Gong J.H., Loetscher P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J Biol Chem 2003, 278:289-295.
117. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:595-602.
118. Oldenhove G., Bouladoux N., Wohlfert E.A., Hall J.A., Chou D., Dos Santos L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
119. O'Connor R.A., Leech M.D., Suffner J., Hämmerling G.J., Anderton S.M. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J Immunol 2010, 185:7235-7243.
120. Sawitzki B., Kingsley C.I., Oliveira V., Karim M., Herber M., Wood K.J. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005, 201:1925-1935.
121. Ouaked N., Mantel P.Y., Bassin C., Burgler S., Siegmund K., Akdis C.A., et al. Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol 2009, 182:1041-1049.
122. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
123. Ziegler S.F., Buckner J.H. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 2009, 11:594-598.
124. Ayyoub M., Deknuydt F., Raimbaud I., Dousset C., Leveque L., Bioley G., et al. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 2009, 106:8635-8640.
125. Voo K.S., Wang Y.H., Santori F.R., Boggiano C., Wang Y.H., Arima K., et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009, 106:4793-4798.
126. Beriou G., Costantino C.M., Ashley C.W., Yang L., Kuchroo V.K., Baecher-Allan C., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
127. + T-cell recruitment to target tissues. Eur J Immunol 2009, 39:1671-1681.
128. Kitamura K., Farber J.M., Kelsall B.L. CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype. J Immunol 2010, 185:3295-3304.
129. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
130. Lohoff M., Mittrücker H.W., Prechtl S., Bischof S., Sommer F., Kock S., et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A 2002, 99:11808-11812.
131. Ahyi A.N., Chang H.C., Dent A.L., Nutt S.L., Kaplan M.H. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol 2009, 183:1598-1606.
132. Rengarajan J., Mowen K.A., McBride K.D., Smith E.D., Singh H., Glimcher L.H. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 2002, 195:1003-1012.
133. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 19:351-356.